The New York Stock Exchange and Nasdaq accused a senior regulator who supervises them of having ethical conflicts, raising the ante in a battle with Washington over how the companies sell market data
The New York Stock Exchange and Nasdaq Inc. on Monday accused a senior regulator who supervises them of having ethical conflicts, raising the ante in a battle with Washington over how the companies sell market data.
The feud stems from a regulatory decision last year on data fees that could crimp exchanges’ profits from selling products that display current market prices and trading interest. The exchanges have appealed the Securities and Exchange Commission’s move to the U.S. Court of Appeals for the District of Columbia...
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Daimler's stock drops as diesel scandal cuts profit for Mercedes' parent companyShare's of German automaker Daimler fell almost 4% in Monday trading after the company said Sunday that profits for the second quarter would be hurt by troubles from its Mercedes-Benz brand and downgraded its earnings forecast for the the full year.
Read more »
Stock-index futures point cautiously higher as investors await G-20 meetingStock-index futures point to a slightly higher start for Wall Street Monday, building on the previous week’s gains, as investors look ahead to a meeting...
Read more »
Eldorado Resorts clinches $18 billion cash and stock deal for Caesars: sourcesU.S. casino operator Eldorado Resorts Inc has agreed to merge with Caesars Enter...
Read more »
20+ Affordable Swimsuits to Stock Up On NowSwimsuit prices are baffling. Here are more than 20 swimsuits for any budget.
Read more »
FedEx is a 'bottom-fishing' stock heading into earnings, technical analyst saysFedEx heads into earnings this week well off its highs, but one technical analyst says the worst could be over for the delivery company.
Read more »
Palatin's stock rockets after FDA OK to market sexual desire disorder treatmentShares of Palatin Technologies Inc. rocketed 27% in very active premarket trading Monday, after a positive Food and Drug Administration decision on AMAG...
Read more »